Description of Goods
Opacifying preprations for X-ray examinations; diagnostic reagents designed to be administered to the patient
Chapter
30 - Pharmaceutical products
Sub Chapter
3006 - Pharmaceutical goods specified in note 4 to this chapter
CGST
2.5%
SGST
2.5%
IGST
5%
CESS
0%
Exempt (0%) only for the 37 life-saving drugs, mostly for cancer and rare diseases (such as Daratumumab, Risdiplam and Emicizumab), listed in Annexure I; 5% for all other goods. Source: Notification 10/2025-Central Tax (Rate), S. No. 113 and Annexure I.